Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Enovis (NYSE: ENOV) will host a first quarter 2026 earnings conference call and live webcast on May 7, 2026 at 8:30 a.m. ET, with an earnings press release issued earlier that morning.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis (NYSE: ENOV) will host a first quarter 2026 earnings conference call and live webcast on May 7, 2026 at 8:30 a.m. ET, with an earnings press release issued earlier that morning.
The live webcast, presentation materials, and a replay will be available in the Investors section of Enovis' website at www.enovis.com.
Details
News Market Reaction – ENOV
On Apr 10, the day this news came out, ENOV closed 1.75% above the previous close.
Data tracked by StockTitan Argus for the Apr 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2026 financial results on Thursday, May 7th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and use Conference ID: 3314793. A link to a replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.